1. Home
  2. EAD vs ALVOW Comparison

EAD vs ALVOW Comparison

Compare EAD & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EAD
  • ALVOW
  • Stock Information
  • Founded
  • EAD 2003
  • ALVOW N/A
  • Country
  • EAD United States
  • ALVOW Luxembourg
  • Employees
  • EAD N/A
  • ALVOW 999
  • Industry
  • EAD Finance/Investors Services
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EAD Finance
  • ALVOW Health Care
  • Exchange
  • EAD Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • EAD N/A
  • ALVOW N/A
  • IPO Year
  • EAD N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • EAD $7.03
  • ALVOW $2.40
  • Analyst Decision
  • EAD
  • ALVOW
  • Analyst Count
  • EAD 0
  • ALVOW 0
  • Target Price
  • EAD N/A
  • ALVOW N/A
  • AVG Volume (30 Days)
  • EAD 178.9K
  • ALVOW N/A
  • Earning Date
  • EAD 01-01-0001
  • ALVOW N/A
  • Dividend Yield
  • EAD 8.91%
  • ALVOW N/A
  • EPS Growth
  • EAD N/A
  • ALVOW N/A
  • EPS
  • EAD N/A
  • ALVOW N/A
  • Revenue
  • EAD N/A
  • ALVOW N/A
  • Revenue This Year
  • EAD N/A
  • ALVOW N/A
  • Revenue Next Year
  • EAD N/A
  • ALVOW N/A
  • P/E Ratio
  • EAD N/A
  • ALVOW N/A
  • Revenue Growth
  • EAD N/A
  • ALVOW N/A
  • 52 Week Low
  • EAD $5.69
  • ALVOW N/A
  • 52 Week High
  • EAD $6.81
  • ALVOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • EAD 56.54
  • ALVOW N/A
  • Support Level
  • EAD $6.85
  • ALVOW N/A
  • Resistance Level
  • EAD $7.11
  • ALVOW N/A
  • Average True Range (ATR)
  • EAD 0.04
  • ALVOW 0.00
  • MACD
  • EAD 0.00
  • ALVOW 0.00
  • Stochastic Oscillator
  • EAD 50.00
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: